Bioavailability file: Terbutaline

  • Yasemin Karabey
  • , Selma Şahin
  • , Levent Öner
  • , A. Atilla Hincal

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

Terbutaline, a synthetic β2-adrenoceptor (β2AR) stimulant, is used mainly in respiratory medicine (bronchial asthma, chronic bronchitis and emphysema) and in obstetrics. It exists as a racemic mixture (+ and - terbutaline). Although (-) terbutaline is responsible for β-agonist activity, (+) terbutaline is devoid of such pharmacological activity. Terbutaline is incompletely absorbed from the gastrointestinal tract. Its bioavailability is low (10-15%) and stereo selective. It is subject to fairly extensive first pass metabolism by sulfate conjugation in the liver and possibly in the gut wall. In this review, physicochemical and pharmacological properties, pharmacokinetics and bioavailability of terbutaline are discussed.

Original languageEnglish
Pages (from-to)149-160
Number of pages12
JournalFabad Journal of Pharmaceutical Sciences
Volume28
Issue number3
Publication statusPublished - Sept 2004

Keywords

  • Asthma
  • Bioavailability
  • Enantiomer
  • Pharmacokinetics
  • Terbutaline
  • β2-agonists

Fingerprint

Dive into the research topics of 'Bioavailability file: Terbutaline'. Together they form a unique fingerprint.

Cite this